nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—ABCB1—adrenal gland cancer	0.802	1	CbGaD
Dabigatran etexilate—F2—posterior vena cava—adrenal gland cancer	0.0622	0.418	CbGeAlD
Dabigatran etexilate—F2—vein—adrenal gland cancer	0.0274	0.184	CbGeAlD
Dabigatran etexilate—F2—urine—adrenal gland cancer	0.0161	0.108	CbGeAlD
Dabigatran etexilate—CES2—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.00753	0.152	CbGpPWpGaD
Dabigatran etexilate—CES2—adrenal cortex—adrenal gland cancer	0.00474	0.0319	CbGeAlD
Dabigatran etexilate—CES1—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.00444	0.0894	CbGpPWpGaD
Dabigatran etexilate—NQO2—adrenal cortex—adrenal gland cancer	0.00424	0.0285	CbGeAlD
Dabigatran etexilate—CES2—E2F transcription factor network—RRM1—adrenal gland cancer	0.00399	0.0804	CbGpPWpGaD
Dabigatran etexilate—CES2—gonad—adrenal gland cancer	0.00393	0.0264	CbGeAlD
Dabigatran etexilate—CES2—cardiac atrium—adrenal gland cancer	0.00392	0.0264	CbGeAlD
Dabigatran etexilate—CES2—pituitary gland—adrenal gland cancer	0.00383	0.0258	CbGeAlD
Dabigatran etexilate—NQO2—cardiac atrium—adrenal gland cancer	0.00351	0.0236	CbGeAlD
Dabigatran etexilate—UGT2B7—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00343	0.069	CbGpPWpGaD
Dabigatran etexilate—NQO2—pituitary gland—adrenal gland cancer	0.00343	0.023	CbGeAlD
Dabigatran etexilate—CES2—adrenal gland—adrenal gland cancer	0.00342	0.023	CbGeAlD
Dabigatran etexilate—F2—adrenal gland—adrenal gland cancer	0.00307	0.0207	CbGeAlD
Dabigatran etexilate—NQO2—adrenal gland—adrenal gland cancer	0.00306	0.0206	CbGeAlD
Dabigatran etexilate—CES1—adrenal gland—adrenal gland cancer	0.00282	0.019	CbGeAlD
Dabigatran etexilate—CES1—E2F transcription factor network—RRM1—adrenal gland cancer	0.00235	0.0474	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of IGF Activity by IGFBP—IGF2—adrenal gland cancer	0.00175	0.0352	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—RB1—adrenal gland cancer	0.00115	0.0232	CbGpPWpGaD
Dabigatran etexilate—CES2—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00106	0.0214	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.00101	0.0204	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.000969	0.0195	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000919	0.0185	CbGpPWpGaD
Dabigatran etexilate—ABCB1—adrenal cortex—adrenal gland cancer	0.000915	0.00615	CbGeAlD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.000867	0.0175	CbGpPWpGaD
Dabigatran etexilate—ABCB1—gonad—adrenal gland cancer	0.000758	0.0051	CbGeAlD
Dabigatran etexilate—ABCB1—pituitary gland—adrenal gland cancer	0.000739	0.00497	CbGeAlD
Dabigatran etexilate—CES1—E2F transcription factor network—RB1—adrenal gland cancer	0.000678	0.0136	CbGpPWpGaD
Dabigatran etexilate—ABCB1—adrenal gland—adrenal gland cancer	0.00066	0.00444	CbGeAlD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000642	0.0129	CbGpPWpGaD
Dabigatran etexilate—CES1—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000626	0.0126	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.000596	0.012	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—MED12—adrenal gland cancer	0.00059	0.0119	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00058	0.0117	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.000577	0.0116	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.000519	0.0105	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000489	0.00984	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Biological oxidations—POMC—adrenal gland cancer	0.000444	0.00893	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.000398	0.00801	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SDHB—adrenal gland cancer	0.000397	0.00799	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.000385	0.00775	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000384	0.00774	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.000378	0.00761	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000377	0.00759	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000343	0.0069	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000295	0.00595	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000293	0.0059	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000276	0.00556	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000276	0.00555	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000267	0.00537	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000266	0.00535	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—TSHR—adrenal gland cancer	0.000261	0.00526	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SDHD—adrenal gland cancer	0.000256	0.00515	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—RRM1—adrenal gland cancer	0.000256	0.00515	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000251	0.00506	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000251	0.00505	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00024	0.00483	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000233	0.0047	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—TP53—adrenal gland cancer	0.000221	0.00446	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—REN—adrenal gland cancer	0.000216	0.00435	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000202	0.00407	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—POMC—adrenal gland cancer	0.000202	0.00407	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.0002	0.00403	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SPARC—adrenal gland cancer	0.000198	0.004	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—MED12—adrenal gland cancer	0.000191	0.00384	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SDHB—adrenal gland cancer	0.000181	0.00364	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PRKACA—adrenal gland cancer	0.000167	0.00337	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000165	0.00333	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—POMC—adrenal gland cancer	0.000164	0.00331	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000158	0.00319	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000152	0.00306	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00015	0.00303	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000148	0.00298	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000147	0.00297	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SDHB—adrenal gland cancer	0.000147	0.00296	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000144	0.0029	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CDC42—adrenal gland cancer	0.000142	0.00286	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PRKACA—adrenal gland cancer	0.000139	0.0028	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000138	0.00277	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000137	0.00277	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IGF2—adrenal gland cancer	0.000137	0.00276	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—GNAS—adrenal gland cancer	0.000136	0.00273	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000134	0.0027	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000134	0.0027	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000129	0.00261	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—RRM1—adrenal gland cancer	0.000116	0.00234	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SDHD—adrenal gland cancer	0.000116	0.00234	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000116	0.00233	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GNAS—adrenal gland cancer	0.000113	0.00227	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ABCB1—adrenal gland cancer	0.000111	0.00223	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—IGF2—adrenal gland cancer	0.000108	0.00217	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000102	0.00206	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—POMC—adrenal gland cancer	0.000102	0.00206	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PRKACA—adrenal gland cancer	9.61e-05	0.00194	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—RRM1—adrenal gland cancer	9.46e-05	0.00191	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SDHD—adrenal gland cancer	9.46e-05	0.00191	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CDC42—adrenal gland cancer	8.98e-05	0.00181	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNRH1—adrenal gland cancer	8.87e-05	0.00179	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MED12—adrenal gland cancer	8.68e-05	0.00175	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GNAS—adrenal gland cancer	8.58e-05	0.00173	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CDC42—adrenal gland cancer	8.15e-05	0.00164	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SPRY2—adrenal gland cancer	8.12e-05	0.00163	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TSHR—adrenal gland cancer	7.91e-05	0.00159	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GNAS—adrenal gland cancer	7.79e-05	0.00157	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—POMC—adrenal gland cancer	7.59e-05	0.00153	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	7.51e-05	0.00151	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MEN1—adrenal gland cancer	7.44e-05	0.0015	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—POMC—adrenal gland cancer	7.19e-05	0.00145	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MED12—adrenal gland cancer	7.05e-05	0.00142	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SDHB—adrenal gland cancer	6.73e-05	0.00136	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PRKACA—adrenal gland cancer	6.33e-05	0.00128	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	6.3e-05	0.00127	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—adrenal gland cancer	6.05e-05	0.00122	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—POMC—adrenal gland cancer	5.78e-05	0.00116	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PRKACA—adrenal gland cancer	5.68e-05	0.00114	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	5.52e-05	0.00111	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—POMC—adrenal gland cancer	5.24e-05	0.00106	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PRKACA—adrenal gland cancer	5.15e-05	0.00104	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GNAS—adrenal gland cancer	5.13e-05	0.00103	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CTNNB1—adrenal gland cancer	5.13e-05	0.00103	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	5.04e-05	0.00101	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ABCB1—adrenal gland cancer	5.04e-05	0.00101	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	5.03e-05	0.00101	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	4.94e-05	0.000996	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDC42—adrenal gland cancer	4.82e-05	0.00097	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF2—adrenal gland cancer	4.64e-05	0.000935	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNAS—adrenal gland cancer	4.6e-05	0.000927	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF1R—adrenal gland cancer	4.49e-05	0.000904	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—RRM1—adrenal gland cancer	4.34e-05	0.000874	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SDHD—adrenal gland cancer	4.34e-05	0.000874	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TP53—adrenal gland cancer	4.34e-05	0.000874	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GNAS—adrenal gland cancer	4.17e-05	0.00084	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ABCB1—adrenal gland cancer	4.09e-05	0.000824	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.08e-05	0.000823	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.92e-05	0.000789	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TERT—adrenal gland cancer	3.86e-05	0.000778	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—POMC—adrenal gland cancer	3.46e-05	0.000696	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—BAD—adrenal gland cancer	3.36e-05	0.000677	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.29e-05	0.000662	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MED12—adrenal gland cancer	3.24e-05	0.000652	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—POMC—adrenal gland cancer	3.1e-05	0.000624	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—BRAF—adrenal gland cancer	3.06e-05	0.000616	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—EGFR—adrenal gland cancer	2.97e-05	0.000597	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—POMC—adrenal gland cancer	2.81e-05	0.000566	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—adrenal gland cancer	2.76e-05	0.000555	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.36e-05	0.000475	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—adrenal gland cancer	2.24e-05	0.000451	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CTNNB1—adrenal gland cancer	2.21e-05	0.000445	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.91e-05	0.000385	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EGFR—adrenal gland cancer	1.75e-05	0.000353	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TP53—adrenal gland cancer	1.47e-05	0.000296	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—POMC—adrenal gland cancer	1.29e-05	0.000259	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.03e-05	0.000207	CbGpPWpGaD
